PTPN2 and triple-negative breast carcinoma: These preclinical findings appear to be relevant to human tumors, since low PTPN2 protein in triple-negative breast cancer (TNBC) is accompanied with TILs/T cells and increased PD-L1 levels, whereas low PTPN2 mRNA is associated with improved survival10.